All In MedTech

FDA Clearance Tracker · P000021

DIMENSION(R) RXL PSA FLEX(R) REAGENT CARTRIDGE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Jul 5, 2001 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jul 5, 2001

Approved

Time to decision

395 days

Received Jun 5, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class II

The decision

FDA number
P000021
Device name
DIMENSION(R) RXL PSA FLEX(R) REAGENT CARTRIDGE
Applicant location
Newark, DE
Received
Jun 5, 2000
Decided
Jul 5, 2001
Decision
Approved
Supplements
45 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class II
Regulation
21 CFR 866.6010

Every decision under product code LTJ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE DIMENSION(R) RXL PSA FLEX(R) REAGENT CARTRIDGE. THE DEVICE IS INDICATED FOR THE FOLLOWING: THE PSA METHOD FOR THE DIMENSION(R) CLINICAL CHEMISTRY SYSTEM WITH THE HETEROGENEOUS IMMUNOASSAY MODULE IS AN IN VITRO DIAGNOSTIC TEST INTENDED TO QUANTITATIVELY MEASURE PROSTATE SPECIFIC ANTIGEN (PSA) IN HUMAN SERUM: 1) AS AN AID IN THE DETECTION OF PROSTATE CANCER WHEN USED IN CONJUNCTION WITH DIGITAL RECTAL EXAM (DRE) IN MEN AGED 50 YEARS OR OLDER. PROSTATE BIOPSY IS REQUIRED FOR THE DIAGNOSIS OF CANCER. 2) AS AN AID IN THE MANAGEMENT (MONITORING) OF PROSTATE CANCER PATIENTS.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LTJ. The earliest in FDA's data is P850048-S002, decided Jul 10, 1987.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Siemens Healthcare Diagnostics

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.